Alpha Cognition Inc., a biotech firm operating under the name 03 Life Sciences, announced today that it has filed meeting materials for its upcoming annual general meeting of shareholders. The meeting is scheduled for September 27, 2024, with a record date set for August 21, 2024, to determine shareholders entitled to vote.

The management information circular, dated August 21, 2024, and other voting materials were filed with Canadian securities commissions on SEDAR+ and are incorporated into this report by reference. These documents are essential for shareholders as they contain information regarding the proceedings and items to be discussed at the annual meeting.

The filing, submitted on August 28, 2024, as indicated in the SEC Form 8-K, is a standard regulatory requirement that provides shareholders with information about the company’s governance and upcoming decisions that require shareholder approval.

Alpha Cognition, previously known as Neurodyn Cognition Inc., is a company focused on biological products, excluding diagnostic substances. The company is incorporated in British Columbia, Canada, and has its principal executive offices located in Vancouver.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.